News | Computed Tomography (CT) | December 03, 2020

Riverain Technologies Gains TGA Approval for ClearRead Xray Confirm (Enhanced) and ClearRead CT

The company’s ClearRead Xray Confirm (Enhanced) and ClearRead CT – breakthrough lung nodule detection applications­ – have received clearance for sale in Australia

The company’s ClearRead Xray Confirm (Enhanced) and ClearRead CT – breakthrough lung nodule detection applications­ – have received clearance for sale in Australia

December 3, 2020 — Riverain Technologies, a U.S.-based developer of artificial intelligence (AI)-powered software that analyzes chest X-rays and computed tomography (CT) images – announced Wednesday that the Therapeutic Goods of Australia (TGA) cleared more of the company’s AI solutions for sale and distribution in Australia, including ClearRead CT and ClearRead Xray Confirm (Enhanced). These solutions are joining ClearRead Xray Bone Suppress and ClearRead Xray Compare that have been TGA-cleared since 2009.

ClearRead solutions significantly improve a clinician’s ability to accurately and efficiently detect disease, suppressing vessels in thoracic CT and bone structures in chest X-ray images for earlier, more efficient detection of lung abnormalities. Powered by the most advanced machine learning and modeling methods available to the medical imaging market, the patented, FDA-cleared, CE marked, and now TGA-cleared software tools are deployable in the clinic or the Cloud:

  • ClearRead Xray applications improve reading efficiency and accuracy and optimize the diagnostic value of all portable and upright images.
  • ClearRead CT supports concurrent reading, allowing for faster reading with proven automatic nodule detection performance for all nodule types.

ClearRead solutions are in use globally, including Germany, Japan, Australia, Canada, and many institutions in the United States.

For more information: www.riveraintech.com

Related Content

For years telehealth has danced at the edges of healthcare
Feature | Teleradiology | January 21, 2021 | By Jef Williams
All indications point to 2021 being the year of the return path of this boomerang event that sent us all in a differe
Steinberg Diagnostic Medical Imaging headquarters.

Steinberg Diagnostic Medical Imaging headquarters.

Sponsored Content | Case Study | Contrast Media Injectors | January 21, 2021
Steinberg Diagnostic Medical Imaging (SDMI) was founded 30 years a
Radiologists have recently taken on the role of activists and are tackling pressing issues in healthcare, including breast density

Getty Images

Feature | Women's Health | January 20, 2021 | By Fazila Seker, Ph.D.
Radiologists — who have long been professionals in the metaphorical and literal back-rooms of healthcare — have recen
The key trends Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Imagesbserved at 2020 Radiological Society of North America (RSNA) meeting all focused around COVID-19 (SARS-CoV-2) and the impact it has had on radiology. #RSNA #RSNA20 #RSNA2020

Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Images

Feature | RSNA | January 20, 2021 | By Melinda Taschetta-Millane and Dave Fornell
MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI.

MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI. Image courtesy of Exact Imaging

Feature | Prostate Cancer | January 20, 2021 | By Brian Wodlinger, Ph.D.
Historically when a patient had an elevated PSA (prostate specific antigen) test their urologist would take the next
An interview with Eric Liederman, M.D., MPH, Director of Medical Informatics for The Permanente Medical Group, in Kaiser Permanente’s Northern California Region, on the explosion of telemedicine in the COVID-19 era

Getty Images

Feature | Radiology Business | January 20, 2021 | By Melinda Taschetta-Millane
Vendor neutral archives enable a single, central location to store large volumes of radiology data, but now need to be able to house data from dozens of other departments with a wide array of data formats. This article originally ran as an introduction to the Vendor Neutral Archives comparison chart.
Feature | Vendor Neutral Archive (VNA) | January 20, 2021 | By Dave Fornell
Most radiologists and clinicians are not trained as...
According to a new research report1 on the contrast media injectors published by MarketsandMarkets, the market was estimated to be $1.3 billion in 2020 and projected to reach $1.9 billion by 2025, at a compound annual growth rate (CAGR) of 7.4 percent over 2020-2025.

The ulrich CTmotion

Feature | Contrast Media Injectors | January 20, 2021 | By Melinda Taschetta-Millane
According to a new...
Previously approved by FDA in the USA, MyLab X8 expands the reach of the MyLab Ultrasound Product Line with a fully featured premium imaging solution, integrating the latest technologies and delivering superior image quality without compromising workflow or efficiency.
News | Ultrasound Imaging | January 20, 2021
January 20, 2021 — Esaote North America announces that the...